EQS-News: Race Oncology Ltd
Race Oncology welcomes positive pre-IND meeting for Zantrene

24.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.


0.jpgContact Details

Gregg Castano

+1 203-762-5649

gregg.castano@newsdirect.com


News Source: News Direct


24.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Race Oncology Ltd
United States
ISIN: AU000000RAC3
EQS News ID: 1496749

 
End of News EQS News Service

1496749  24.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1496749&application_name=news&site_id=boersennews